Spectral AI Completes Proof of Concept for Wound Measurement Technology
Spectral AI (Nasdaq: MDAI) has completed a proof-of-concept for its wound measurement technology that calculates the total body surface area (TBSA) of burns. This technology, integrated into the DeepView® System for burn indication (DeepView AI®-Burn), provides fast, accurate, and standardized measurements to improve patient treatment decisions.
Unlike current methods, Spectral AI's technology utilizes image capture to deliver distance, area, and volume measurements with sub-millimetric accuracy, without manual markers. It generates burn size and depth calculations in seconds, aiding clinicians in treatment decisions. The company believes this technology offers a more comprehensive representation of acute burn injuries and could potentially change the standard of care in burn wound treatment.
Spectral AI (Nasdaq: MDAI) ha completato una prova di concetto per la sua tecnologia di misurazione delle ferite che calcola l'area totale della superficie corporea (TBSA) delle ustioni. Questa tecnologia, integrata nel sistema DeepView® per l'indicazione delle ustioni (DeepView AI®-Burn), offre misurazioni rapide, accurate e standardizzate per migliorare le decisioni di trattamento dei pazienti.
Contrariamente ai metodi attuali, la tecnologia di Spectral AI utilizza la cattura di immagini per fornire misurazioni di distanza, area e volume con un'accuratezza sub-millimetrica, senza indicatori manuali. Genera calcoli della dimensione e della profondità delle ustioni in pochi secondi, supportando i clinici nelle decisioni di trattamento. L'azienda ritiene che questa tecnologia offra una rappresentazione più completa delle lesioni acute da ustione e potrebbe potenzialmente cambiare lo standard di cura nel trattamento delle ferite da ustioni.
Spectral AI (Nasdaq: MDAI) ha completado una prueba de concepto para su tecnología de medición de heridas que calcula el área total de la superficie corporal (TBSA) de las quemaduras. Esta tecnología, integrada en el sistema DeepView® para indicación de quemaduras (DeepView AI®-Burn), proporciona mediciones rápidas, precisas y estandarizadas para mejorar las decisiones de tratamiento de los pacientes.
A diferencia de los métodos actuales, la tecnología de Spectral AI utiliza la captura de imágenes para ofrecer mediciones de distancia, área y volumen con precisión submilimétrica, sin marcadores manuales. Genera cálculos del tamaño y la profundidad de las quemaduras en segundos, ayudando a los clínicos en las decisiones de tratamiento. La compañía cree que esta tecnología ofrece una representación más completa de las lesiones agudas por quemaduras y podría cambiar el estándar de atención en el tratamiento de heridas por quemaduras.
스펙트럴 AI(Nasdaq: MDAI)는 화상에 대한 전체 신체 표면적(TBSA)을 계산하는 상처 측정 기술의 개념 증명을 완료했습니다. 이 기술은 화상 지시를 위한 DeepView® 시스템(DeepView AI®-Burn)에 통합되어 있으며, 빠르고 정확하며 표준화된 측정값을 제공하여 환자 치료 결정을 개선합니다.
현재 방법과는 달리, 스펙트럴 AI의 기술은 이미지 캡처를 통해 수동 마커 없이 거리, 면적 및 부피 측정값을 서브 밀리미터 단위로 제공합니다. 몇 초 만에 화상의 크기와 깊이 계산을 생성하여 임상의들이 치료 결정을 내리는 데 도움을 줍니다. 이 회사는 이 기술이 급성 화상 부상의 보다 포괄적인 표현을 제공하며, 화상 치료의 표준을 변화시킬 수 있다고 믿고 있습니다.
Spectral AI (Nasdaq: MDAI) a achevé une preuve de concept pour sa technologie de mesure des plaies qui calcule la surface corporelle totale (TBSA) des brûlures. Cette technologie, intégrée au système DeepView® pour l'indication des brûlures (DeepView AI®-Burn), fournit des mesures rapides, précises et standardisées pour améliorer les décisions de traitement des patients.
Contrairement aux méthodes actuelles, la technologie de Spectral AI utilise la capture d'images pour fournir des mesures de distance, de surface et de volume avec une précision sub-millimétrique, sans marqueurs manuels. Elle génère des calculs de taille et de profondeur des brûlures en quelques secondes, aidant les cliniciens dans leurs décisions de traitement. L'entreprise est convaincue que cette technologie offre une représentation plus complète des blessures par brûlure aiguë et pourrait potentiellement modifier le standard de soins dans le traitement des plaies par brûlure.
Spectral AI (Nasdaq: MDAI) hat einen Machbarkeitsnachweis für seine Wundmessungstechnologie abgeschlossen, die die gesamte Körperoberfläche (TBSA) von Verbrennungen berechnet. Diese Technologie, die in das DeepView®-System zur Anzeige von Verbrennungen (DeepView AI®-Burn) integriert ist, bietet schnelle, präzise und standardisierte Messungen, um die Behandlungsentscheidungen der Patienten zu verbessern.
Im Gegensatz zu den aktuellen Methoden nutzt die Technologie von Spectral AI die Bildaufnahme, um Abstands-, Flächen- und Volumenmessungen mit sub-millimetergenauer Genauigkeit ohne manuelle Marker zu liefern. Sie generiert in Sekunden Berechnungen zu Größe und Tiefe der Verbrennungen und unterstützt die Kliniker bei den Behandlungsentscheidungen. Das Unternehmen ist der Ansicht, dass diese Technologie eine umfassendere Darstellung von akuten Verbrennungsverletzungen bietet und möglicherweise den Behandlungsstandard bei Verbrennungswunden verändern könnte.
- Completion of proof-of-concept for wound measurement technology
- Technology integrated into DeepView® System for burn indication
- Provides fast, accurate, and standardized measurements
- Delivers distance, area, and volume measurements with sub-millimetric accuracy
- Generates burn size and depth calculations in seconds
- Potential to change the standard of care in burn wound treatment
- None.
Insights
Spectral AI's completion of the proof-of-concept for their wound measurement technology marks a significant advancement in burn care. The technology's ability to calculate total body surface area (TBSA) of burns with sub-millimetric accuracy addresses a critical need in acute burn management. Current methods often lead to miscalculations, potentially resulting in suboptimal treatment decisions.
The integration of this technology into the DeepView® System for burn indication (DeepView AI®-Burn) offers several key advantages:
- Provides immediate, objective and binary assessment of burn wound healing trajectory
- Delivers accurate measurements of distance, area and volume without manual markers
- Generates burn size and depth calculations within seconds
This development could significantly improve the standard of care in burn treatment by enhancing the speed and accuracy of initial assessments, which are important for determining appropriate interventions. The technology's potential to reduce human error and provide standardized measurements across different care settings is particularly noteworthy.
While this news is promising, investors should note that the technology is still in the proof-of-concept stage. The next steps would likely involve clinical validation and regulatory approvals before potential commercialization. The market impact will depend on successful implementation and adoption by healthcare providers.
Provides Clinicians with Superior Wound Size Measurement Information that Improves Patient Treatment Decisions
DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of a proof-of-concept module of its wound measurement technology that calculates the total body surface area (“TBSA”) of a burn. This technology, which is currently integrated into the Company’s DeepView® System for burn indication (“DeepView AI®-Burn”), provides a fast, accurate, and standardized measurement that the Company believes is a significant improvement over current wound size measurement technology and can improve patient treatment decisions.
Burn size estimation is a crucial component of acute burn management. The speed and accuracy of determining burn size at the earliest stages of care is critical in making treatment decisions.
Current wound size measurement methods are limited in their ability to measure the three wound dimensions of distance, area and volume. This limitation can cause miscalculations in accurately sizing the wound and result in suboptimal treatment decisions.
In contrast, Spectral AI’s proprietary wound measurement technology utilizes the same image capture produced by DeepView AI®-Burn that provides an immediate, objective and binary assessment of a burn wound’s healing trajectory to also deliver distance, area and volume measurements with sub-millimetric accuracy without reference to any attendant markers or manually placed stickers. In seconds, a burn size and depth calculation is generated to further aid clinicians in determining next step treatment decisions.
“Our wound measurement technology delivers a more comprehensive representation of an acute burn injury than currently used methods, and provides a level of accuracy, uniformity, and standardization that we believe has been missing from burn care,” said Peter M. Carlson, Chief Executive Officer. “We believe that this data can help reduce human error and provide invaluable clinician support regardless of the care setting. This technology strengthens our conviction that DeepView AI®-Burn has the potential to change the standard of care in burn wound treatment.”
Spectral AI's DeepView® System for burn indication is designed to distinguish between healing and non-healing tissue by providing an immediate and binary prediction of wound healing on Day One that can support clinical decision-making regarding next step treatment plans.
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. The DeepView® System is a predictive device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal to change the current standard of care, the DeepView® System is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView® System, visit www.spectral-ai.com.
Forward Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
Investors:
The Equity Group
Devin Sullivan
Managing Director
dsullivan@equityny.com
Conor Rodriguez
Analyst
crodriguez@equityny.com
FAQ
What new technology has Spectral AI (MDAI) developed for burn treatment?
How does Spectral AI's (MDAI) wound measurement technology differ from current methods?
What is the potential impact of Spectral AI's (MDAI) new wound measurement technology on burn care?
How is Spectral AI's (MDAI) wound measurement technology integrated into their existing products?
